Anthony Delucchi

Tony leads Denali’s CMC program strategy, external manufacturing and supply chain efforts for all therapeutic modalities.

Prior to joining Denali in 2018 Tony held roles of increasing responsibility at Genentech leading CMC teams from pre-IND through post launch, most recently leading the commercial CMC teams for Avastin and the Lytics franchise. Tony was responsible for numerous site selection evaluations and development of CMC strategies for programs throughout the product life-cycle. Earlier in his career Tony worked in recovery process development at Bayer and manufacturing support at Chiron.

Tony holds B.S. and M.S. degrees in Biology from University of the Pacific.